About Us

GlycoSyn is a business unit of Industrial Research Ltd. - working closely with biotechnology clients around the globe to ensure high quality and fast-paced development of high-value small molecules.

We provide contract Discovery, Process Development and cGMP Manufacture of small molecules for pre-clinical and clinical trials to Phase 2.

GlycoSyn recognises the value and confidentiality of intellectual property. That allows us to offer services under contract without claim to any discovery, improvement or gain in efficiency, realised during that contract.

In short, as our client, you own and retain 100% of your valued intellectual property at all times. It's all part of our over-riding philosophy.

Chemistry Expertise

Discovery

GlycoSyn is supported by Carbohydrate Chemistry expertise within Industrial Research Ltd. This means access to 30 PhD Synthetic Organic Chemists specialising in the rationale design of Carbohydrate drug candidates, multi-step synthesis and natural products Chemistry. For more information visit, www.irl.cri.nz/carbo.

Carbohydrate Chemistry staff are engaged under exclusive contract to GlycoSyn for commercial discovery and bench level synthetic chemistry. GlycoSyn produces material for early stage drug discovery requirements, by providing

• custom synthesis
• lead optimisation
• analytical method development
• bench level synthesis

Process Development

GlycoSyn's Process Development division consists of 10 PhD Synthetic Organic Chemists and Engineers specialising in the scale-up, optimisation and proto-type manufacture of small molecules. The division transitions small molecule discovery and bench chemistry to multi-kilogram scale synthesis as a precursor to cGMP manufacture.

The Process Development division can manufacture non-cGMP small molecules by synthesis at the 20 or 50 Litre scale to produce material for toxicology, stability and pre-clinical requirements.

cGMP Manufacture

GlycoSyn's cGMP Manufacturing division consists of 14 highly experienced Chemists, Engineers, Quality, Analytical and Support personnel specialising in the synthesis, manufacture and analytical method validation of cGMP small molecules.

We operate under stringent international Chemical Manufacturing and Control protocols to ensure the highest standards for the manufacture of small molecules for use in human clinical trials to Phase 2

GlycoSyn can manufacture cGMP small molecules by Synthesis at the 50 or 250 Litre scale to produce material for pre-clinical, stability, formulation and clinical requirements.